Globavend
3 hedge funds and large institutions have $31.1K invested in Globavend in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.
0.01% less ownership
Funds ownership: 0.01% → 0% (-0.01%)
50% less funds holding
Funds holding: 6 → 3 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
89% less capital invested
Capital invested by funds: $277K → $31.1K (-$246K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$8.78K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$154K |
| 2 |
VF
Virtu Financial
New York
|
-$24K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$20.6K |
| 4 |
HF
HRT Financial
New York
|
-$15K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$88 |
GVH Hedge Fund Activity: Q3 2024 in Review
3 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Globavend (GVH) for Q3 2024, worth a combined $31.1K — down 89% from $277K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of GVH and 1 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $8.78K. The largest seller was UBS Group, cutting an estimated $154K.
- 3 institutional investors held Globavend (GVH) as of Q3 2024, down from 6 in Q2 2024.
- Funds reported $31.1K of Globavend stock for Q3 2024, down 89% quarter-over-quarter.
- 1 fund opened new Globavend positions in Q3 2024 and 4 closed out, a net change of -3 holders.
- The largest Globavend buyer in Q3 2024 was Two Sigma Securities, an estimated $8.78K added.
- The largest Globavend seller in Q3 2024 was UBS Group, an estimated $154K sold.
Based on aggregated 13F filings for Q3 2024.